No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
VTR240621C50000
- 0.72
- -0.03-4.00%
15min DelayClose Jun 14 16:00 ET
0.72High0.60Low
0.60Open0.75Pre Close59 Volume1.98K Open Interest50.00Strike Price3.56KTurnover20.97%IV1.24%PremiumJun 21, 2024Expiry Date0.10Intrinsic Value100Multiplier5DDays to Expiry0.62Extrinsic Value100Contract SizeAmericanOptions Type0.5480Delta0.2998Gamma83.50Leverage Ratio-0.0514Theta0.0042Rho45.75Eff Leverage0.0249Vega
Intraday
- 5D
- 1D
News
Baird Adjusts Price Target on Ventas to $51 From $49
Ventas (VTR) has an average rating of outperform and price targets ranging from $49 to $69, according to analysts polled by Capital IQ.
Express News | Ventas Inc : BMO Raises Target Price to $57 From $53
BMO Capital Adjusts Price Target on Ventas to $57 From $53, Keeps Outperform Rating
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $52
Scotiabank analyst Nicholas Yulico maintains $Ventas Inc(VTR.US)$ with a hold rating, and adjusts the target price from $51 to $52.According to TipRanks data, the analyst has a success rate of 50.0% a
Scotiabank Adjusts Price Target on Ventas to $52 From $51
Ventas (VTR) has an average outperform rating and a price target range of $49 to $69, according to analysts polled by Capital IQ.
Express News | Ventas Inc : Scotiabank Raises Target Price to $52 From $51
Comments
Analyst Connor Siversky predicts OHI and NHI's rent coverage will increase due to improving portfolio metrics. However, he doubts VTR's senior housing portfolio improvement will offset high leverage and limited investment opportunities. He also suggests OHI's dividend will be covered in late 2024, and NHI is set to drive growth with a strong liquidity profile.
Omega Healthcare, National Health Investors Upgraded to Overweight at Wells Fargo 1
follow for daily top watchlist ⭐️
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
1
$Affirm Holdings(AFRM.US$ initiated at neutral by Compass Point, announced target price at $15.00.
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
15
Upgrades
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
18
2
Read more